Recombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitro

<p>Abstract</p> <p>Background</p> <p>Recent studies indicate an increase in tumor progression and recurrence in head and neck squamous cell carcinomas (HNSCC) of cancer patients taking recombinant human erythropoietin (rhEpo) for anemia. This study was undertaken to inv...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Abhold Eric, Rahimy Elham, Wang-Rodriguez Jessica, Blair Katherine J, Yu Michael A, Brumund Kevin T, Weisman Robert A, Ongkeko Weg M
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BMC 2011-12-01
श्रृंखला:BMC Research Notes
ऑनलाइन पहुंच:http://www.biomedcentral.com/1756-0500/4/553
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन